Indaptus Therapeutics

Company snapshot

Indaptus Therapeutics is a pharma organization headquartered in NEW YORK, NY, USA. It trades on NYSE under ticker INDP. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 1 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 1 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Indaptus Therapeutics. Not investment advice.

• What is Indaptus Therapeutics?

  Indaptus Therapeutics is a pharma organization headquartered in NEW YORK, NY, USA. It trades on NYSE under ticker INDP. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 1 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources

• Is Indaptus Therapeutics publicly traded?

  Yes. Indaptus Therapeutics is listed with ticker INDP on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Indaptus Therapeutics develop or market?

  No drug profiles are currently linked to Indaptus Therapeutics. Pipeline programs may still list investigational assets.

• What are the latest developments for Indaptus Therapeutics?

  In the last 12 months our linked public records show 0 trial program update(s) and 1 US patent grant(s) tied to this profile.

• What therapeutic areas does Indaptus Therapeutics focus on?

  No specific therapeutic focus areas are currently identified for Indaptus Therapeutics in our database.